INVST’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$449K Buy
1,836
+156
+9% +$36.3K 0.05% 257
2025
Q4
$348K Sell
1,680
-104
-6% -$20.6K 0.04% 258
2025
Q3
$331K Sell
1,784
-45
-2% -$7.71K 0.04% 262
2025
Q2
$279K Buy
1,829
+78
+4% +$12K 0.03% 265
2025
Q1
$290K Sell
1,751
-7,715
-82% -$1.21M 0.04% 248
2024
Q4
$1.37M Sell
9,466
-824
-8% -$128K 0.17% 88
2024
Q3
$1.67M Buy
10,290
+8,207
+394% +$1.31M 0.2% 78
2024
Q2
$305K Buy
2,083
+218
+12% +$32.4K 0.03% 210
2024
Q1
$294K Sell
1,865
-7,880
-81% -$1.25M 0.03% 193
2023
Q4
$1.54M Sell
9,745
-592
-6% -$90.8K 0.2% 72
2023
Q3
$1.61M Buy
10,337
+520
+5% +$85.8K 0.23% 62
2023
Q2
$1.62M Sell
9,817
-39
-0.4% -$6.29K 0.24% 53
2023
Q1
$1.61M Buy
9,856
+445
+5% +$71.9K 0.25% 55
2022
Q4
$1.54M Sell
9,411
-444
-5% -$76.7K 0.24% 56
2022
Q3
$1.58M Buy
9,855
+222
+2% +$37.6K 0.27% 47
2022
Q2
$1.64M Sell
9,633
-233
-2% -$41.5K 0.25% 53
2022
Q1
$1.75M Buy
9,866
+264
+3% +$44.9K 0.29% 53
2021
Q4
$1.55M Buy
9,602
+931
+11% +$152K 0.24% 60
2021
Q3
$1.4M Buy
8,671
+339
+4% +$57.8K 0.22% 66
2021
Q2
$1.4M Buy
8,332
+455
+6% +$75.3K 0.23% 60
2021
Q1
$1.28M Buy
7,877
+1,183
+18% +$191K 0.22% 59
2020
Q4
$1.05M Buy
6,694
+2,032
+44% +$300K 0.19% 62
2020
Q3
$687K Buy
4,662
+240
+5% +$35.5K 0.16% 69
2020
Q2
$621K Buy
4,422
+1,874
+74% +$273K 0.18% 64
2020
Q1
$328K Sell
2,548
-5
-0.2% -$709 0.14% 64
2019
Q4
$372K Sell
2,553
-59
-2% -$8K 0.14% 59
2019
Q3
$339K Buy
2,612
+16
+0.6% +$2.11K 0.15% 60
2019
Q2
$362K Sell
2,596
-78
-3% -$10.8K 0.19% 43
2019
Q1
$372K Sell
2,674
-16
-0.6% -$2.14K 0.19% 40
2018
Q4
$347K Buy
2,690
+47
+2% +$6.56K 0.2% 34
2018
Q3
$369K Sell
2,643
-283
-10% -$37.6K 0.19% 37
2018
Q2
$355K Buy
2,926
+130
+5% +$16.2K 0.21% 39
2018
Q1
$348K Buy
2,796
+61
+2% +$8.24K 0.22% 32
2017
Q4
$382K Buy
2,735
+344
+14% +$47.9K 0.28% 29
2017
Q3
$311K Buy
+2,391
New +$317K 0.27% 26

Other funds holding JNJ

INVST's JNJ Position: Q1 2026 in Review

INVST increased its Johnson & Johnson (JNJ) stake by 9.3% in Q1 2026, buying an estimated $36.3K and bringing the position to 1,836 shares worth $449K. The position accounts for 0.05% of the portfolio, ranked #257.

INVST first reported a position in JNJ in Q3 2017 and has held it in 35 quarters since. The position peaked at $1.75M in Q1 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • INVST held 1,836 shares of Johnson & Johnson worth $449K as of Q1 2026.
  • INVST bought 156 Johnson & Johnson shares in Q1 2026, an estimated $36.3K.
  • Johnson & Johnson made up 0.05% of INVST's portfolio in Q1 2026, its #257 holding.
  • INVST first reported a position in Johnson & Johnson in Q3 2017 and has held it in 35 quarters since.
  • INVST's Johnson & Johnson position peaked at $1.75M in Q1 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on INVST's 13F filing for Q1 2026, filed 13 May 2026.